The utility of inflammatory and endothelial factors in the prognosis of severe dengue.
暂无分享,去创建一个
S. Sivasubramanian | K. Ramkumar | Sundhar Mohandas | K. Kaveri | Poovazhagi Varadarajan | V. Gopalan | Karthikeyan Govindan | Velu Vimal Raj
[1] M. Quam,et al. Global burden for dengue and the evolving pattern in the past 30 years. , 2021, Journal of travel medicine.
[2] R. Maude,et al. Diagnostic accuracy of the WHO clinical definitions for dengue and implications for surveillance: A systematic review and meta-analysis , 2021, PLoS neglected tropical diseases.
[3] J. Nugraha,et al. MCP-1 LEVELS AND ATYPICAL LYMPHOCYTES IN EARLY FEVER OF DENGUE VIRUS INFECTION WITH NON-STRUCTURAL PROTEIN 1 (NS-1) ANTIGEN TEST IN dr DARSONO HOSPITAL, PACITAN , 2020 .
[4] E. Konishi,et al. Cytokine Expression in Dengue Fever and Dengue Hemorrhagic Fever Patients with Bleeding and Severe Hepatitis , 2020, The American journal of tropical medicine and hygiene.
[5] S. Hay,et al. The current and future global distribution and population at risk of dengue , 2019, Nature Microbiology.
[6] M. Borca,et al. The Role of Interleukin 6 During Viral Infections , 2019, Front. Microbiol..
[7] M. S. Sajib,et al. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology , 2019, Cells.
[8] G. Ogg,et al. Pathogenesis of vascular leak in dengue virus infection , 2017, Immunology.
[9] Sivaporn Inyoo,et al. Synergistic Effect of TNF-α and Dengue Virus Infection on Adhesion Molecule Reorganization in Human Endothelial Cells. , 2017, Japanese journal of infectious diseases.
[10] P. Young,et al. Clinical and Laboratory Diagnosis of Dengue Virus Infection , 2017, The Journal of infectious diseases.
[11] I. Khanna,et al. Dengue Fever: Causes, Complications, and Vaccine Strategies , 2016, Journal of immunology research.
[12] Jian Wang,et al. Slow resolution of inflammation in severe adult dengue patients , 2016, BMC Infectious Diseases.
[13] Simon I Hay,et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.
[14] H. Wertheim,et al. Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study , 2016, The Journal of infectious diseases.
[15] S. Hasan,et al. Dengue virus: A global human threat: Review of literature , 2016, Journal of International Society of Preventive & Community Dentistry.
[16] S. Halstead,et al. Dengue infection , 2016, Nature Reviews Disease Primers.
[17] F. Diaz-Quijano,et al. Dengue Patients Treated with Doxycycline Showed Lower Mortality Associated to a Reduction in IL-6 and TNF Levels. , 2015, Recent patents on anti-infective drug discovery.
[18] K. Alitalo,et al. Endothelial destabilization by angiopoietin-2 via integrin β1 activation , 2015, Nature Communications.
[19] Jian Wang,et al. Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults , 2015, Emerging Microbes & Infections.
[20] M. Álvarez-Mon,et al. Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. , 2014, Virology.
[21] M. Teixeira,et al. Inflammatory and innate immune responses in dengue infection: protection versus disease induction. , 2013, The American journal of pathology.
[22] W. Liles,et al. Biomarkers of endothelial activation/dysfunction in infectious diseases , 2013, Virulence.
[23] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[24] P. D. de Groot,et al. Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability. , 2012, The American journal of tropical medicine and hygiene.
[25] S. Hadinegoro,et al. The revised WHO dengue case classification: does the system need to be modified? , 2012, Paediatrics and international child health.
[26] Stephen J. Thomas,et al. Vaccines for the prevention of dengue: Development update , 2011, Human vaccines.
[27] N. Wauquier,et al. Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production , 2010, BMC infectious diseases.
[28] Rosanna W. Peeling,et al. Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.
[29] S. Green,et al. Markers of dengue disease severity. , 2010, Current topics in microbiology and immunology.
[30] Yee‐Shin Lin,et al. Dengue virus induces thrombomodulin expression in human endothelial cells and monocytes in vitro. , 2009, The Journal of infection.
[31] V. Videm,et al. Soluble ICAM‐1 and VCAM‐1 as Markers of Endothelial Activation , 2008, Scandinavian journal of immunology.
[32] Pieter H. Reitsma,et al. Differential Gene Expression Changes in Children with Severe Dengue Virus Infections , 2008, PLoS neglected tropical diseases.
[33] Kuender D Yang,et al. Implications of Dynamic Changes among Tumor Necrosis Factor-α (TNF-α), Membrane TNF Receptor, and Soluble TNF Receptor Levels in Regard to the Severity of Dengue Infection , 2007 .
[34] S. Yoksan,et al. Elevated Soluble Thrombomodulin in the Febrile Stage Related to Patients at Risk for Dengue Shock Syndrome , 2006, The Pediatric infectious disease journal.
[35] A. Atrasheuskaya,et al. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. , 2003, FEMS immunology and medical microbiology.
[36] N. M. Dung,et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] Y. S. Lin,et al. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. , 2000, The American journal of tropical medicine and hygiene.
[38] W. Buurman,et al. Role of TNFR1 and TNFR2 in TNF-induced platelet consumption in mice. , 1998, Journal of immunology.
[39] A. Issekutz,et al. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes , 1997, Journal of virology.